Source:http://linkedlifedata.com/resource/pubmed/id/17154346
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-6-11
|
pubmed:abstractText |
Our objective was to evaluate the incidence of adverse patient outcomes due to drug-drug interactions (D-DIs), the type of drugs involved and the underlying reason. As a proxy for adverse patient outcomes, emergency department (ED) visits, hospital admissions and re-hospitalisations were assessed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1053-8569
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2006 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
641-51
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Hospitalisations and emergency department visits due to drug-drug interactions: a literature review.
|
pubmed:affiliation |
Pharmaco-epidemiology Unit, Department of Epidemiology & Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Review
|